Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.65
Delayed Data
As of Apr 20
 +0.02 / +0.55%
Today’s Change
2.58
Today|||52-Week Range
5.66
+26.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-69.0M-5.0M-61.7M-85.2M
 
 
 
 
 
Depreciation489.0K694.0K955.0K1.1M
 
 
 
 
 
Total Other Cash Flow8.3M9.6M11.4M10.6M
 
 
 
 
 
Funds From Operations-60.2M5.3M-49.3M-73.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.7M-323.0K16.3M-14.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-55.5M5.6M-65.7M-59.5M
 
 
 
 
 
 
InvestingIncrease In Investments-79.3M-692.5M-499.1M-345.5M
 
 
 
 
 
Decrease In Investments123.6M394.6M562.3M372.1M
 
 
 
 
 
Capital Expenditures-947.0K-704.0K-2.5M-626.0K
 
 
 
 
 
Net Cash Flow Investing43.3M-298.7M60.7M26.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings440.0K229.0K444.0K-175.0K
 
 
 
 
 
Long Term Debt Reduction-313.0K-249.0K-246.0K-351.0K
 
 
 
 
 
Net Proceeds Stock Sale52.3M301.2M322.0K264.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing52.4M301.1M520.0K-262.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash40.2M8.1M-4.5M-33.8M